Last reviewed · How we verify

NCT06097377

Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study

Completed Last updated 24 October 2023
What this trial tests

trial in Tetralogy of Fallot in 10 participants. Completed in 1 September 2023.

Timeline
1 November 2021
Primary endpoint
1 September 2023
1 September 2023

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusCompleted
Study typeOBSERVATIONAL
Enrollment10
Start date1 November 2021
Primary completion1 September 2023
Estimated completion1 September 2023
Sites1 location across Denmark

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 6 to 18, any sex, with Tetralogy of Fallot or Lymphatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines subclinical lymphatic abnormalities in Tetralogy of Fallot patients, utilizing lymphatic magnetic resonance and near-infrared fluorescence imaging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tetralogy of Fallot

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06097377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing